Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Metex Noovistago is a leading European industrial biotechnology company specializing in the production of fermentation-based amino acids for animal nutrition. Formed in 2021 through the acquisition of Ajinomoto Animal Nutrition Europe by Metabolic Explorer (METEX), the company operates a major production site in Amiens, France. Its product portfolio includes essential amino acids such as lysine, tryptophan, threonine, and valine, which are used to optimize livestock diets and reduce the environmental footprint of farming. The company utilizes advanced metabolic engineering and large-scale fermentation technologies to produce bio-based alternatives to chemically synthesized ingredients. In 2024, following financial challenges, the company's assets were acquired by the Avril Group and Bpifrance, leading to a rebranding of the operations back to the historical name Eurolysine.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Metex Noovistago.